Literature DB >> 17351539

[Wolfram's syndrome presenting as a cerebellar ataxia].

S Mathis1, V Paquis, V Mesnage, I Balaboï, R Gil, B Gilbert, J P Neau.   

Abstract

INTRODUCTION: Wolfram syndrome is a genetic disease with recessive autosomic transmission, associating early-onset diabetes mellitus and bilateral optical atrophy. CASE REPORT: We report the case of a 47-year-old patient for whom we diagnosed a Wolfram syndrome in view of a late neurological syndrome in association with ataxia and bilateral horizontal nystagmus. The brain resonance magnetic imaging revealed a major atrophy of the brainstem and cerebellum.
CONCLUSION: Wolfram syndrome is a rare pathology, with fatal consequences before the age of 50. The association of diabetes mellitus and optical atrophy, especially when there are other symptoms (ataxia, deafness, diabetes insipidus, neuropsychiatric manifestations or urinary tract disorders) should lead to this diagnosis and to carry out a genetic confirmation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351539     DOI: 10.1016/s0035-3787(07)90391-4

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

1.  Hypergonadotropic hypogonadism, progressive early-onset spinocerebellar ataxia, and late-onset sensorineural hearing loss: case report and literature review.

Authors:  E Sarikaya; Cg Ensert; Hc Gulerman
Journal:  Balkan J Med Genet       Date:  2011-12       Impact factor: 0.519

2.  Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.

Authors:  Agnieszka Zmyslowska; Bogdan Malkowski; Wojciech Fendler; Maciej Borowiec; Karolina Antosik; Piotr Gnys; Dobromila Baranska; Wojciech Mlynarski
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

3.  Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram Syndrome.

Authors:  Sarah A Eisenstein; Raveena S Boodram; Courtney L Sutphen; Heather M Lugar; Brian A Gordon; Bess A Marshall; Fumihiko Urano; Anne M Fagan; Tamara Hershey
Journal:  Front Neurosci       Date:  2022-04-12       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.